Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.
<h4>Background</h4>Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent t...
Guardado en:
Autores principales: | Mattia C F Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg, EuResist study group, Virolab study group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains.
por: João Dinis de Sousa, et al.
Publicado: (2010) -
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.
por: Dineke Frentz, et al.
Publicado: (2010) -
Only slight impact of predicted replicative capacity for therapy response prediction.
por: Hendrik Weisser, et al.
Publicado: (2010) -
Comparison of two simulators for individual based models in HIV epidemiology in a population with HSV 2 in Yaoundé (Cameroon)
por: Diana M. Hendrickx, et al.
Publicado: (2021) -
Use of evidence-based practices in pregnancy and childbirth: South East Asia Optimising Reproductive and Child Health in Developing Countries project.
por: SEA-ORCHID Study Group, et al.
Publicado: (2008)